Elevations in soluble CD40 ligand in patients with high platelet aggregability undergoing percutaneous coronary intervention

High aggregatory responses despite antiplatelet treatment is associated with an increased risk of thrombotic complications following percutaneous coronary intervention (PCI). In the present study, we investigated the relationship between platelet aggregatory responses to ADP and the release of CD40L...

Full description

Saved in:

Bibliographic Details
Published in:	Blood coagulation & fibrinolysis Vol. 20; no. 4; pp. 283 - 289
Main Authors:	Obradovic, Slobodan D, Antovic, Jovan P, Antonijevic, Nebojsa M, Ratkovic, Nenad G, Vojvodic, Danilo V, Subota, Vesna S, Gligic, Branko Lj, Obradovic, Dragana V, Marinkovic, Jelena M, Wallen, Håkan N
Format:	Journal Article
Language:	English
Published:	Hagerstown, MD Lippincott Williams & Wilkins, Inc 01-06-2009 Lippincott Williams & Wilkins
Subjects:	Acute Coronary Syndrome - blood Acute Coronary Syndrome - therapy Adenosine Diphosphate - pharmacology Aged Biological and medical sciences Blood coagulation. Blood cells Cardiac Catheterization CD40 Ligand - blood Female Fundamental and applied biological sciences. Psychology Hematologic and hematopoietic diseases Humans Immunologic Factors - blood Male Medical sciences Medicin och hälsovetenskap Middle Aged Molecular and cellular biology P-Selectin - blood Platelet Aggregation Platelet diseases and coagulopathies Risk Factors Thrombosis - blood Human Angioplasty Cell adhesion molecule Instrumentation therapy Thienopyridine Soluble form platelet aggregation Aggregation P Selectin Platelet percutaneous coronary intervention soluble P-selectin Hemostasis CD40 ligand Platelet function thienopyridines soluble CD40-ligand
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!